Discovery of potential RIPK1 inhibitors by machine learning and molecular dynamics simulations
- 14 November 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 25 (45) , 31418-31430
Abstract
Six small molecules from virtual screening hits may treat neurodegenerative diseases and SARS-CoV-2 by inhibiting RIPK1.Keywords
Funding Information
- National Natural Science Foundation of China (82173429)
This publication has 53 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- The future of the protein data bankBiopolymers, 2012
- H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulationsNucleic Acids Research, 2012
- Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening EnrichmentsJournal of Chemical Information and Modeling, 2010
- Receptor-interacting protein (RIP) kinase familyCellular & Molecular Immunology, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 1998
- Causality in structure—activity studiesJournal of Computational Chemistry, 1985
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983